Navigation Links
Renowned Radiologist Peter J. Julien, MD Named Radlink Chief Medical Officer
Date:2/26/2008

2005 Cedar Sinai 'Physician of the Year' and Current Radlink Board Member

Joins Team

REDONDO BEACH, Calif., Feb. 26 /PRNewswire/ -- Radlink, Inc., a fast-growing software and hardware company that has emerged as an innovative provider of medical imaging systems to healthcare providers, today named Peter J. Julien, MD, as chief medical officer.

With nearly 30 years of experience, Dr. Julien is currently director of Thoracic Imaging at Cedar-Sinai Medical Center in Los Angeles. He also has served as associate director of Radiology and director of Mammography. In 2005, Dr. Julien was named the Cedar-Sinai Physician of the Year. Dr. Julien, who is a Radlink board member, will continue his duties at Cedar-Sinai.

"Peter is an investor and board member of Radlink," said Tom Hacking, chairman and CEO. "Over the last two years he has spent countless hours working with our team to design and test software products that our niche market -- private practice physicians -- have told us they need to make a smooth transition to digital imaging. This appointment simply acknowledges publicly the important role Peter has played in the development of Radlink's imaging products."

As chief medical officer, Dr. Julien will guide Radlink's imaging strategy including new product ideas and determining how the company can best economically and technologically serve private practice physicians as their offices become digital.

"Working with Radlink over the last two years gives me a unique perspective into the company, its products and its goals," said Dr. Julien. "They are truly offering top quality and affordable products that can help change the economical landscape of medicine. My background will play an integral role in helping to accomplish these objectives and I'm honored to be on the team."

In addition to a long career at Cedar-Sinai for more than 25 years, Dr. Julien was an assistant clinical professor of
'/>"/>

SOURCE Radlink, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
2. Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer
3. EPI-Q, Inc. Expands Capabilities with Addition of Anthony Vita, MD, MPH and Peter Herout, PharmD
4. Peter Cummings to receive the 2007 AIChE Nanoscale Science and Engineering Forum Award
5. Hsiao Dee Lieu, M.D., F.A.C.C. Named VP of Clinical Research of Nile Therapeutics
6. CareEvolution and SCHIEx Named Interoperability Finalists for 2008 Microsoft Healthcare Users Group (MS-HUG) Healthcare Innovation Awards
7. Meredith Martin Addy Named One of Top 10 Illinois Super Lawyers for 2008
8. Carl Hull Named President and Chief Operating Officer of Gen-Probe
9. Dr. Charles A. Sims of California Cryobanks Family Cord Blood Services Named to National Stem Cell Advisory Council
10. Lota Zoth Elected to Ikaria Board and Named Audit Committee Chair
11. Twenty-One Brinks Hofer Gilson & Lione Attorneys Named 2008 Illinois Super Lawyers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... NEW YORK , May 22, 2013 /PRNewswire/ ... pioneering the development of disease modifying therapeutics for ... today the completion of its Series B financing, ... shares and warrants that would represent approximately $2.8M ... investors and new investors supported the raise. ...
(Date:5/22/2013)... N.H. , May 22, 2013  Superior ... the Year 2013" by Business NH Magazine.  For ... Granite State organizations that distinguish themselves with extraordinary ... very proud to receive this honor," said ... Controls.  "As with any recognition, this award is ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Genedata, ... industrial biotechnology, drug discovery, and life science research, ... Selector ™ as its bioinformatics platform for ... organisms. Genedata will provide AB Enzymes, one of ... a hosted solution of Genedata Selector accompanied by ...
(Date:5/22/2013)... 22, 2013 AudioNotch ... for tinnitus treatment. AudioNotch is pleased to announce ... clinic locations in both British Columbia and Alberta, ... and hearing services. AudioNotch's tinnitus treatment program is ... entering a Destination Hearing clinic, patients have the ...
Breaking Biology Technology:Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2
... on QuatRx clinical development programs, including review of positive results ... ... ANN ARBOR, Mich., Jan. 4 QuatRx Pharmaceuticals Company,today announced that ... presenter at the 26th Annual JP Morgan Healthcare,Conference on Tuesday, January ...
... the Company has been invited and has accepted to ... January 7-10, 2008 at,the Westin St. Francis Hotel in ... Chief Executive Officer will provide an,overview of the Company ... About JPMorgan 26th Annual Healthcare Conference, JPMorgan,s premier ...
... safety and efficacy in treatment of multi-drug ... resistant infections ... or the "Company"), a biopharmaceutical company focused on the,development of novel ... the first patients in two,separate Phase 2 clinical trials. The studies ...
Cached Biology Technology:QuatRx Pharmaceuticals to Present at 26th Annual JP Morgan Healthcare Conference 2Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741 2Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741 3
(Date:5/21/2013)... ANN ARBORThe new University of Michigan Water Center ... to support Great Lakes restoration and protection efforts. ... will support diverse projects, including efforts to track ... effectiveness of techniques to control non-native weedy plant ... and monitor fish responses to restoration activities. , ...
(Date:5/21/2013)... scientists have developed many devices that can reopen clogged ... effective, each of these treatments has drawbacks, including the ... MIT analyzes the potential usefulness of a new treatment ... stents, but may pose fewer risks. With this new ... only a brief period, during which it releases a ...
(Date:5/20/2013)... are also commonly resistant to antimicrobial substances made ... in mBio , the online open-access journal ... colistin and host antimicrobials LL-37 and lysozyme, which ... mean that patients with life-threatening multi-drug resistant infections ... Colistin is a last-line drug for treating several ...
Breaking Biology News(10 mins):U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3
... Montral, June 23, 2009 On June 18, the ... $9.16 million for the creation of a national technology ... platform, headed by Dr. Benoit Coulombe from the Institut ... provide Canadian researchers with new state-of-the-art equipment in proteomics, ...
... 2009) University of Minnesota Medical School researchers have discovered an ... to treat those infected by a parasitic flatworm. ... The Schistosomasis parasite infects about 200 million people in ... where people become infected simply by bathing, drinking, or cooking water ...
... whips up more powerful and frequent hurricanes and storms, the ... breed and recover from damage. That,s one of the ... corals in the wake of large climate-driven bleaching and storm ... the regrowth of young corals drops sharply in ...
Cached Biology News:A Canada-wide technology platform for mapping the human interactome 2U of M study finds new insight on therapy for a devastating parasitic disease 2Coral face 'a stormy future' 2
... The IEC Centra CL3 series ... in typical research and clinical applications ... broad accessory package includes quick connect ... An advanced yet intuitive interface allows ...
PP2B-Abeta (C-20)...
DNA Polymerase I Large (Klenow) Fragment is a DNA polymerase that lacks the 5'Cut Site3' exodeoxyribonuclease activity of intact DNA Polymerase I but it contains the 3'Cut Site5' exodeoxyribonuclease...
... H2OBIT™ is a fully licensed, high throughput, water ... of up to 24 microplates. This equates to ... A robotic arm rapidly transfers a ... in temperature ramping times that are considerably faster ...
Biology Products: